Chemoinformaics analysis of (E,Z)-Pseudoionone
| Molecular Weight | 192.302 | nRot | 5 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 4 |
| Exact Molecular Weight | 192.151 | nRing | 0 |
| Solubility: LogS | -2.883 | nHRing | 0 |
| Solubility: LogP | 3.33 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 35.8479 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.367 |
| Synth | 2.841 |
| Natural Product Likeliness | 2.537 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.896 |
| Pgp-sub | 0.013 |
| HIA | 0.006 |
| CACO-2 | -4.473 |
| MDCK | 0.000031 |
| BBB | 0.131 |
| PPB | 0.918485 |
| VDSS | 2.729 |
| FU | 0.0642528 |
| CYP1A2-inh | 0.629 |
| CYP1A2-sub | 0.516 |
| CYP2c19-inh | 0.233 |
| CYP2c19-sub | 0.888 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.706 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.65 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.38 |
| CL | 1.879 |
| T12 | 0.766 |
| hERG | 0.05 |
| Ames | 0.23 |
| ROA | 0.124 |
| SkinSen | 0.962 |
| Carcinogencity | 0.679 |
| EI | 0.985 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.606658 |